ASPEN AEROGELS INC - 8-K Filing
Aspen Aerogels reports Q3 2026 revenue of $85.2 million, exceeding high-end guidance with a 71% quarter-over-quarter increase. (Items: 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $ASPN
Read the full article at SEC EDGAR
Part of the story Zedge, Inc. - 8-K Filing (63 articles)